From: The external validity of published randomized controlled trials in primary care
Characteristics | Total Trials | Median Number Needed to Screen to Identify One Participant (Interquartile Range) | P Value |
---|---|---|---|
Total | 103 | ||
Journal | 0.78 | ||
BMJ | 44 | 2.95 (1.42–9.30) | |
British Journal of General Practice | 31 | 2.30 (1.38–4.42) | |
Family Practice | 17 | 1.81 (1.23–3.46) | |
Journal of Family Practice | 11 | 2.79 (1.95–7.92) | |
Number of enrolees | 0.40 | ||
<100 | 40 | 3.15 (1.63–5.64) | |
110–260 | 31 | 2.19 (1.22–9.95) | |
260–650 | 15 | 1.66 (1.32–3.11) | |
>650 | 17 | 2.78 (1.38–5.16) | |
Multicentre | |||
Multiple | 83 | 2.79 (1.42–6.33) | |
Single | 16 | 2.05 (1.18–7.83) | |
Unclear | 3 | 1.66 (1.60–5.95) | |
Funding Source | 0.09 | ||
Charity | 10 | 2.61 (1.23–4.48) | |
Governing body | 3 | 1.60(1.60–6.06) | |
Government | 55 | 2.14 (1.34–6.33) | |
Pharma Industry | 8 | 3.98 (2.10–15.59) | |
Other | 9 | 5.33 (1.95–7.92) | |
Not Listed | 18 | 2.62 (1.23–3.48) | |
Intervention Studied | 0.47 | ||
Counselling/Lifestyle | 8 | 4.75 (2.05–169.71) | |
Decision Support aids | 6 | 2.89 (1.42–17.21) | |
Educational | 21 | 2.05 (1.34–3.63) | |
Pharmaceutical therapy | 9 | 1.89 (1.66–5.16) | |
Surgery/procedure | 3 | 1.59 (1.11–9.95) | |
Other | 55 | 2.79 (1.42–6.38) |